Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance

Justin Anthony Chen, Yanli Hou, Krishna M. Roskin, Daniel A. Arber, Charles D. Bangs, Linda B. Baughn, Athena M. Cherry, Mark D. Ewalt, Andrew Z. Fire, Laure Fresard, Hutton M. Kearney, Stephen B. Montgomery, Robert S. Ohgami, Kathryn E. Pearce, Beth A. Pitel, Jason D. Merker, Jason Gotlib

Blood Adv (2021) 5 (17): 3492–3496.

https://doi.org/10.1182/bloodadvances.2020004174

Published: 2021

Includes: Supplemental data

Journal Articles

Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality

Isabelle A. van Zeventer, Aniek O. de Graaf, Melanie M. van der Klauw, Edo Vellenga, Bert A. van der Reijden, Jan Jacob Schuringa, Arjan Diepstra, Luca Malcovati, Joop H. Jansen, Gerwin Huls

Blood Adv (2021) 5 (17): 3266–3278.

https://doi.org/10.1182/bloodadvances.2021004355

Published: 2021

Includes: Supplemental data

Journal Articles

Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis

Damon E. Houghton, Henny Heisler Billett, Manila Gaddh, Oluwatomiloba Onadeko, Gemlyn George, Tzu-Fei Wang, Thein H. Oo, Mingen Feng, Mahua Dasgupta, Michael Jaglal, Michael B. Streiff, Pippa Simpson, Radhika Gali, Lisa Baumann Kreuziger

Blood Adv (2021) 5 (14): 2807–2812.

https://doi.org/10.1182/bloodadvances.2021004698

Published: 2021

Includes: Supplemental data

Journal Articles

Single-cell ATAC-seq reveals GATA2-dependent priming defect in myeloid and a maturation bottleneck in lymphoid lineages

Serine Avagyan, Margaret C. Weber, Sai Ma, Meera Prasad, William P. Mannherz, Song Yang, Jason D. Buenrostro, Leonard I. Zon

Blood Adv (2021) 5 (13): 2673–2686.

https://doi.org/10.1182/bloodadvances.2020002992

Published: 2021

Includes: Supplemental data

Journal Articles

Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients

Abi Vijenthira, Inna Gong, Stephen D. Betschel, Matthew Cheung, Lisa K. Hicks

Blood Adv (2021) 5 (12): 2624–2643.

https://doi.org/10.1182/bloodadvances.2021004629

Published: 2021

Includes: Supplemental data

Journal Articles

Can palliative care consultation increase integration of palliative care for patients with hematologic malignancies?

Chloé Prod’homme, Licia Touzet, Magali Pierrat, Luc Chevalier, Helene Lesaffre, Celine Berthon, Valerie Coiteux, Sarah Barbieux, David Beauvais, Loïc Bauschert, Marie De Charette, Laure Goursaud, Salomon Manier, Thierry Facon

Blood Adv (2021) 5 (8): 2123–2127.

https://doi.org/10.1182/bloodadvances.2021004369

Published: 2021

Journal Articles

Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years

Isabelle A. van Zeventer, Jonas B. Salzbrunn, Aniek O. de Graaf, Bert A. van der Reijden, H. Marike Boezen, Judith M. Vonk, Pim van der Harst, Jan Jacob Schuringa, Joop H. Jansen, Gerwin Huls

Blood Adv (2021) 5 (8): 2115–2122.

https://doi.org/10.1182/bloodadvances.2020004062

Published: 2021

Includes: Supplemental data

Journal Articles

ETV6-FLT3– positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML

Barbara Spitzer, Filemon S. Dela Cruz, Glorymar D. Ibanez Sanchez, Yanming Zhang, Wenbin Xiao, Ryma Benayed, Alina Markova, M. Irene Rodriguez-Sanchez, Nancy Bouvier, Mikhail Roshal, Andrew L. Kung, Neerav Shukla

Blood Adv (2021) 5 (7): 1899–1902.

https://doi.org/10.1182/bloodadvances.2020003699

Published: 2021

Journal Articles

Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial

Etan Orgel, Celia Framson, Rubi Buxton, Jiyoon Kim, Gang Li, Jonathan Tucci, David R. Freyer, Weili Sun, Matthew J. Oberley, Christina Dieli-Conwright, Steven D. Mittelman

Blood Adv (2021) 5 (7): 1853–1861.

https://doi.org/10.1182/bloodadvances.2020004018

Published: 2021

Includes: Supplemental data

Journal Articles

Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19

Chaja F. Jacobs, Eric Eldering, Arnon P. Kater

Blood Adv (2021) 5 (3): 913–925.

https://doi.org/10.1182/bloodadvances.2020003768

Published: 2021

Includes: Supplemental data

Journal Articles

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

Suhag Parikh, Joel A. Brochstein, Einat Galamidi, Aurélie Schwarzbach, Joanne Kurtzberg

Blood Adv (2021) 5 (3): 843–852.

https://doi.org/10.1182/bloodadvances.2020003248

Published: 2021

Includes: Supplemental data

Journal Articles

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL –negative MPN in blast phase

Vikas Gupta, James A. Kennedy, Jose-Mario Capo-Chichi, Soyoung Kim, Zhen-Huan Hu, Edwin P. Alyea, Uday R. Popat, Ronald M. Sobecks, Bart L. Scott, Aaron T. Gerds, Rachel B. Salit, H. Joachim Deeg, Ryotara Nakamura, Wael Saber

Blood Adv (2020) 4 (21): 5562–5573.

https://doi.org/10.1182/bloodadvances.2020002727

Published: 2020

Includes: Supplemental data

Journal Articles

CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia

Anthony Quagliano, Anilkumar Gopalakrishnapillai, E. Anders Kolb, Sonali P. Barwe

Blood Adv (2020) 4 (18): 4393–4405.

https://doi.org/10.1182/bloodadvances.2020001592

Published: 2020

Includes: Supplemental data

Journal Articles

Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing

Fabienne Lucas, Phillip D. Michaels, Dahai Wang, Annette S. Kim

Blood Adv (2020) 4 (18): 4362–4365.

https://doi.org/10.1182/bloodadvances.2020002306

Published: 2020

Includes: Supplemental data

Journal Articles

Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas

Alexander Neuwelt, Taha Al-Juhaishi, Eduardo Davila, Bradley Haverkos

Blood Adv (2020) 4 (17): 4256–4266.

https://doi.org/10.1182/bloodadvances.2020001966

Published: 2020

Journal Articles

Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm

Naveen Pemmaraju, Marina Konopleva

Blood Adv (2020) 4 (16): 4020–4027.

https://doi.org/10.1182/bloodadvances.2019000173

Published: 2020

Journal Articles

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Blood Adv (2020) 4 (16): 3913–3925.

https://doi.org/10.1182/bloodadvances.2020001648

Published: 2020

Includes: Supplemental data

Journal Articles

Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies

Blood Adv (2020) 4 (15): 3776–3787.

https://doi.org/10.1182/bloodadvances.2020002509

Published: 2020

Includes: Supplemental data

Journal Articles

End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies

Pamela C. Egan, Thomas W. LeBlanc, Adam J. Olszewski

Blood Adv (2020) 4 (15): 3606–3614.

https://doi.org/10.1182/bloodadvances.2020001767

Published: 2020

Includes: Supplemental data

Journal Articles

Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant

Seongseok Yun, Onyee Chan, Daniel Kerr, Nicole D. Vincelette, Afshan Idrees, Qianxing Mo, Kendra Sweet, Jeffrey E. Lancet, Mohamed A. Kharfan-Dabaja, Ling Zhang, Lubomir Sokol

Blood Adv (2020) 4 (14): 3435–3442.

https://doi.org/10.1182/bloodadvances.2020001875

Published: 2020

Includes: Supplemental data

NARROW

Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance

Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality

Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis

Single-cell ATAC-seq reveals GATA2-dependent priming defect in myeloid and a maturation bottleneck in lymphoid lineages

Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients

Can palliative care consultation increase integration of palliative care for patients with hematologic malignancies?

Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years

ETV6-FLT3– positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML

Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial

Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL –negative MPN in blast phase

CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia

Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing

Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas

Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies

End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies

Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only